Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronan Roussel

Showing results (121-130 of 202) with videos related to

Pageof 21
Sort By:
Cardiovascular Diabetology|October 11, 2022
Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetesManuel Sanchez, Caroline Kannengiesser, Sophie Hoang, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2020
Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 DiabetesMikael Croyal, Pierre-Jean Saulnier, Audrey Aguesse, et al.
Journal of Diabetes and Its Complications|May 17, 2017
Urinary lysophopholipids are increased in diabetic patients with nephropathyJean-Sébastien Saulnier-Blache, Eva Feigerlova, Jean Michel Halimi, et al.
Diabetes Care|June 14, 2018
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR StudyRobert Ritzel, Stewart B Harris, Helen Baron, et al.
Diabetes Care|July 19, 2013
Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuriaGilberto Velho, Nadine Bouby, Samy Hadjadj, et al.
Obesity Surgery|January 28, 2019
Severe Chronic Kidney Disease Is Associated with a Lower Efficiency of Bariatric SurgeryBoris Hansel, Konstantinos Arapis, Diana Kadouch, et al.
Diabetes Care|June 23, 2019
Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680Robert Ritzel, Stewart B Harris, Helen Baron, et al.
Diabetes Care|August 15, 2018
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT TrialJulio Rosenstock, Alice Cheng, Robert Ritzel, et al.
Journal of Medical Internet Research|November 10, 2017
A Fully Automated Web-Based Program Improves Lifestyle Habits and HbA1c in Patients With Type 2 Diabetes and Abdominal Obesity: Randomized Trial of Patient E-Coaching Nutritional Support (The ANODE Study)Boris Hansel, Philippe Giral, Laetitia Gambotti, et al.
Diabetologia|October 22, 2015
Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetesSamy Hadjadj, Bertrand Cariou, Frederic Fumeron, et al.
Pageof 21

Showing results (121-130 of 202) with videos related to

Sort By:
Pageof 21
Cardiovascular Diabetology|October 11, 2022
Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetesManuel Sanchez, Caroline Kannengiesser, Sophie Hoang, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2020
Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 DiabetesMikael Croyal, Pierre-Jean Saulnier, Audrey Aguesse, et al.
Journal of Diabetes and Its Complications|May 17, 2017
Urinary lysophopholipids are increased in diabetic patients with nephropathyJean-Sébastien Saulnier-Blache, Eva Feigerlova, Jean Michel Halimi, et al.
Diabetes Care|June 14, 2018
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR StudyRobert Ritzel, Stewart B Harris, Helen Baron, et al.
Diabetes Care|July 19, 2013
Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuriaGilberto Velho, Nadine Bouby, Samy Hadjadj, et al.
Obesity Surgery|January 28, 2019
Severe Chronic Kidney Disease Is Associated with a Lower Efficiency of Bariatric SurgeryBoris Hansel, Konstantinos Arapis, Diana Kadouch, et al.
Diabetes Care|June 23, 2019
Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680Robert Ritzel, Stewart B Harris, Helen Baron, et al.
Diabetes Care|August 15, 2018
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT TrialJulio Rosenstock, Alice Cheng, Robert Ritzel, et al.
Journal of Medical Internet Research|November 10, 2017
A Fully Automated Web-Based Program Improves Lifestyle Habits and HbA1c in Patients With Type 2 Diabetes and Abdominal Obesity: Randomized Trial of Patient E-Coaching Nutritional Support (The ANODE Study)Boris Hansel, Philippe Giral, Laetitia Gambotti, et al.
Diabetologia|October 22, 2015
Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetesSamy Hadjadj, Bertrand Cariou, Frederic Fumeron, et al.
Pageof 21